News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. Central Command imposed a blockade east of the Strait of Hormuz, allowing interception of unauthorized vessels in the Gulf of Oman and Arabian Sea.
  • Euro-area government bond yields rose as oil jumped and a failed U.S.-Iran truce raised odds of another ECB rate hike by December.
  • Goldman Sachs posted stronger Q1 profit driven by record equities trading and fees, but its shares fell as bank stocks retreated.
  • Goldman cut Best Buy to Sell, citing higher memory costs and margin pressure, and Best Buy shares dropped about 4%.
  • Northland lifted Intel's price target to $92 after increasing its fab-asset multiple, citing strategic partnerships and expanded advanced-node capacity.
  • Pershing Square kicked off roadshows for dual IPOs aiming to raise $5–10 billion via a two-entity structure with PSUS shares priced at $50.
  • Bank of America upgraded Nokia to Buy, citing optical networking strength and rising hyperscaler AI data-center demand.

Latest Articles

Cantor Fitzgerald Raises Onto Innovation to Overweight, Sees Earnings Upside and Strategic Boost from Semilab Deal

Cantor Fitzgerald Raises Onto Innovation to Overweight, Sees Earnings Upside and Strategic Boost from Semilab Deal

Cantor Fitzgerald upgraded Onto Innovation Inc. (NYSE: ONTO) to Overweight from Neutral and increased its price target to $275 from $170, citing expected earnings upside, stronger guidance prospects and strategic benefits from a recent acquisition. The firm projects first-half 2026 revenue of $575 million to $600 million and anticipates higher cale…

ImmunityBio Shares Climb After Positive Regulatory Talks With Saudi FDA

ImmunityBio Shares Climb After Positive Regulatory Talks With Saudi FDA

ImmunityBio's stock rose after constructive discussions with the Saudi Food and Drug Authority (SFDA). The SFDA encouraged a regulatory submission for the company’s recombinant BCG (rBCG) aimed at addressing a BCG shortage for bladder cancer patients in Saudi Arabia, and conversations also opened the door to expanding ANKTIVA use with checkpoint in…

IPO Plans Falter in 2026 as Volatile Markets and Valuation Pressure Bite

IPO Plans Falter in 2026 as Volatile Markets and Valuation Pressure Bite

A wave of postponements and reduced deal sizes has hit 2026 initial public offerings in the United States as market turbulence, tougher valuation checks and weak peer showings curb the pipeline for new listings. Notable issuers including Clear Street, Agibank and Liftoff Mobile have each taken steps to trim or halt plans while monitoring conditions…

ARKO Petroleum Raises $183.2 Million Net in IPO, Lists APC on Nasdaq

ARKO Petroleum Raises $183.2 Million Net in IPO, Lists APC on Nasdaq

ARKO Petroleum Corp. completed its initial public offering on February 13, selling 11,111,111 shares of Class A common stock at $18.00 per share and generating approximately $183.2 million in net proceeds. The Class A shares began trading on the Nasdaq Capital Market under the ticker APC. Parent company ARKO Corp. retained significant economic and …

eToro Posts Q4 Gains, Surpasses Profit Estimates on Multi-Asset Demand

eToro Posts Q4 Gains, Surpasses Profit Estimates on Multi-Asset Demand

eToro reported fourth-quarter adjusted earnings that exceeded analyst expectations, supported by growth across the range of asset classes it offers. The company saw its assets under administration rise year-on-year even as net contribution from crypto and margin-related items declined. Broader market dynamics during the quarter included rising U.S.…

Ocular Therapeutix Shares Slide After SOL-1 Top-Line Results for Axpaxli, Despite Statistically Significant Outcomes

Ocular Therapeutix Shares Slide After SOL-1 Top-Line Results for Axpaxli, Despite Statistically Significant Outcomes

Ocular Therapeutix (OCUL) saw its stock fall 25% after releasing top-line results from the Phase 3 SOL-1 superiority trial of Axpaxli in wet age-related macular degeneration (AMD). The study reached its primary endpoint, with Axpaxli outperforming Regeneron’s Eylea on the percentage of patients maintaining visual acuity at both 36 and 52 weeks. Mar…

Rosenblatt Tacks Buy Rating onto Workday Citing Valuation, CEO Return

Rosenblatt Tacks Buy Rating onto Workday Citing Valuation, CEO Return

Rosenblatt upgraded Workday from Neutral to Buy, assigning a $180 price target that implies about 25% upside from the current $144.42 share price. The firm pointed to a steep stock decline, a free cash flow valuation below 10 times, and the return of co-founder Aneel Bhusri as CEO as supporting factors. Rosenblatt's checks find the business stable …

Saudi Shares Close Lower as Media, Transport and Tourism Weigh on Tadawul

Saudi Shares Close Lower as Media, Transport and Tourism Weigh on Tadawul

Saudi Arabia's stock market finished Tuesday in negative territory, driven by sector-wide declines in Media & Publishing, Transport and Hotels & Tourism. The Tadawul All Share fell 0.77% at the close, with notable individual gains in tourism, financing and education names offset by sharp drops in mining, information systems and learning stocks. Com…

Rosenblatt Launches Coverage on BitGo With Buy Rating, $17 Target

Rosenblatt Launches Coverage on BitGo With Buy Rating, $17 Target

Rosenblatt Securities began coverage of BitGo Holdings (BTGO) with a Buy rating and a $17.00 price objective, signaling significant upside from the current share price. The firm highlighted BitGo's institutional custody and security business, the effect of the GENIUS Act on pipeline activity, and relatively lower exposure to crypto market swings. S…

Berenberg Urges Caution as Valuations Diverge Among European Cable Makers

Berenberg Urges Caution as Valuations Diverge Among European Cable Makers

Berenberg remains positive on the European cable sector, citing structural demand drivers such as data centre expansion, electrification, renewables and grid investment. However, the bank says investors must be selective as valuation gaps widen and medium-term expectations reset, reiterating a Buy on Nexans, downgrading Prysmian to Hold and keeping…

Kyndryl Shares Climb After Form 10-Q Filed; No Restatements Reported

Kyndryl Shares Climb After Form 10-Q Filed; No Restatements Reported

Kyndryl's stock rose 10% after the company filed its Form 10-Q for the quarter ended Dec. 31, 2025, confirming there were no restatements of current or previously reported financial statements. The company also submitted amendments to its 2025 fiscal-year 10-K and two earlier 10-Qs, and disclosed material weaknesses in internal control over financi…